Abstract
Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.
| Original language | English |
|---|---|
| Pages (from-to) | 843-847 |
| Number of pages | 5 |
| Journal | Korean Journal of Family Medicine |
| Volume | 30 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2009 Nov 1 |
Fingerprint
Keywords
- Novel influenza a (H1N1)
- Oseltamivir
- Zanamivir
ASJC Scopus subject areas
- Family Practice
Cite this
Diagnosis and management of novel influenza a (H1N1). / Wie, Seong Heon; Kim, Woo Joo.
In: Korean Journal of Family Medicine, Vol. 30, No. 11, 01.11.2009, p. 843-847.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Diagnosis and management of novel influenza a (H1N1)
AU - Wie, Seong Heon
AU - Kim, Woo Joo
PY - 2009/11/1
Y1 - 2009/11/1
N2 - Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.
AB - Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.
KW - Novel influenza a (H1N1)
KW - Oseltamivir
KW - Zanamivir
UR - http://www.scopus.com/inward/record.url?scp=79961148920&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79961148920&partnerID=8YFLogxK
U2 - 10.4082/kjfm.2009.30.11.843
DO - 10.4082/kjfm.2009.30.11.843
M3 - Article
AN - SCOPUS:79961148920
VL - 30
SP - 843
EP - 847
JO - Korean Journal of Family Medicine
JF - Korean Journal of Family Medicine
SN - 2005-6443
IS - 11
ER -